J

Joinn Laboratories China Co Ltd
SSE:603127

Watchlist Manager
Joinn Laboratories China Co Ltd
SSE:603127
Watchlist
Price: 17.68 CNY -6.31% Market Closed
Market Cap: 11.1B CNY
Have any thoughts about
Joinn Laboratories China Co Ltd?
Write Note

Joinn Laboratories China Co Ltd
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Joinn Laboratories China Co Ltd
Research & Development Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
J
Joinn Laboratories China Co Ltd
SSE:603127
Research & Development
-ÂĄ87.8m
CAGR 3-Years
-25%
CAGR 5-Years
-25%
CAGR 10-Years
N/A
WuXi AppTec Co Ltd
SSE:603259
Research & Development
-ÂĄ1.4B
CAGR 3-Years
-23%
CAGR 5-Years
-23%
CAGR 10-Years
N/A
Pharmaron Beijing Co Ltd
SZSE:300759
Research & Development
-ÂĄ473.9m
CAGR 3-Years
-55%
CAGR 5-Years
-61%
CAGR 10-Years
N/A
WuXi Biologics (Cayman) Inc
HKEX:2269
Research & Development
-ÂĄ788.4m
CAGR 3-Years
-39%
CAGR 5-Years
-29%
CAGR 10-Years
N/A
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Research & Development
-ÂĄ238.3m
CAGR 3-Years
-6%
CAGR 5-Years
-18%
CAGR 10-Years
N/A
W
WuXi XDC Cayman Inc
HKEX:2268
Research & Development
-ÂĄ76.9m
CAGR 3-Years
-166%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Joinn Laboratories China Co Ltd
Glance View

Market Cap
11.1B CNY
Industry
Life Sciences Tools & Services

Joinn Laboratories China Co Ltd is a CN-based company operating in Life Sciences Tools & Services industry. The company is headquartered in Beijing, Beijing and currently employs 2,140 full-time employees. The company went IPO on 2017-08-25. Joinn Laboratories China Co Ltd is a China-based company primarily engaged in the pharmacology and toxicology research of new drugs. Non-clinical research services include drug safety evaluation, pharmacokinetic research as well as pharmacological and pharmacodynamic research. Clinical trials and related services include clinical contract research organization services, phase I clinical research collaboration unit (CRU), and bioanalysis services. Experimental model business mainly includes rodents and non-human primates. The firm conducts its businesses both in the domestic market and overseas markets.

Intrinsic Value
17.6 CNY
Fairly Valued
Intrinsic Value
Price
J

See Also

What is Joinn Laboratories China Co Ltd's Research & Development?
Research & Development
-87.8m CNY

Based on the financial report for Jun 30, 2024, Joinn Laboratories China Co Ltd's Research & Development amounts to -87.8m CNY.

What is Joinn Laboratories China Co Ltd's Research & Development growth rate?
Research & Development CAGR 5Y
-25%

Over the last year, the Research & Development growth was 20%. The average annual Research & Development growth rates for Joinn Laboratories China Co Ltd have been -25% over the past three years , -25% over the past five years .

Back to Top